Zhejiang Da Xue Xue Bao Yi Xue Ban. 2022 Dec 25;51(6):758-764. doi: 10.3724/zdxbyxb-2022-0323.
It was previously thought that hypertrophic cardiomyopathy is the leading cause of sudden cardiac death in athletes. This was also extrapolated to the general population. Thereby, exercise was restrained in patients with hypertrophic cardiomyopathy. However, recent studies have shown that hypertrophic cardiomyopathy is not the main cause of sudden cardiac death, and moderate exercise is not only safe but beneficial for patients with hypertrophic cardiomyopathy. With the accumulation of evidence, relevant guidelines recommend low-intensity exercise from the beginning, then gradually recommend moderate-high intensity exercise for patients with hypertrophic cardiomyopathy. This suggests that we should rediscover the value of exercise in patients with hypertrophic cardiomyopathy. It is now widely accepted that patients with hypertrophic cardiomyopathy can benefit from the positive effects of exercise through an individualized exercise prescription based on a comprehensive assessment. This review summarizes the evidence showing patients with hypertrophic cardiomyopathy can exercise safely, and the methods to formulate related exercise prescriptions.
先前人们认为肥厚型心肌病是运动员心源性猝死的主要原因。这一结论也被推断到了普通人群。因此，肥厚型心肌病患者被限制运动。然而，最近的研究表明，肥厚型心肌病并不是心源性猝死的主要原因，适度运动不仅安全，而且对肥厚型心肌病患者有益。随着证据的积累，相关指南建议从低强度运动开始，然后逐渐为肥厚型心肌病患者推荐中高强度运动。这表明我们应该重新发现运动对肥厚型心肌病患者的价值。现在人们普遍认为，通过基于综合评估的个体化运动处方，肥厚型心肌病患者可以从运动的积极影响中获益。这篇综述总结了表明肥厚型心肌病患者可以安全运动的证据，以及制定相关运动处方的方法。
